Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures
A 30% reduction in long episodes was shown to be associated with…
Veeva Pulse Data Shows New Science Calls for More Connected Engagement
Synchronizing sales and marketing improves outcomes, yet 65% of field engagements are…
Merus Announces FDA Approval of BIZENGRI (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ NonSmall Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study
BIZENGRI® is the first and only therapy approved by the FDA specifically…
KVH Introduces TracNet Coastal and TracNet Coastal Pro 5G/Wi-Fi Terminals and Cellular Data Plans
Powered by KVH Fusion eSIM technology, TracNet Coastal is a high-powered, single-cable,…
Luxurynsight and Heuritech, two French AI & Data Leaders unite to unlock next-level data intelligence for Luxury, Fashion and Beauty Brands
PARIS, Dec. 2, 2024 /PRNewswire/ -- As from November 2024, Heuritech has officially…
Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients…
Atomic Data Becomes Official IT Provider of the Fishers Event Center
MINNEAPOLIS, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Atomic Data today announced a…
Preferred Networks Chooses Digital Realty’s Data Center in Japan for Scalable, Cutting-Edge AI Platform
SINGAPORE, Nov. 19, 2024 /PRNewswire/ -- Digital Realty (NYSE: DLR), the largest…
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting 2024
November 18, 2024 18:00 ET | Source: Pliant Therapeutics, Inc. INTEGRIS-PSC featured…
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
SAN FRANCISCO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq:…